| Date Filed | Type | Description |
| 03/01/2023 |
4
| Springhorn Jeremy P. (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 384 shares
@ $20.41, valued at
$7.8k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2020 |
4
| Springhorn Jeremy P. (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 4 shares
@ $60.94, valued at
$243.8
Sold 803 shares
@ $62.2, valued at
$49.9k
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2019 |
4
| Springhorn Jeremy P. (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Sold 1,210 shares
@ $31.32, valued at
$37.9k
|
|
| 01/29/2019 |
4
| Springhorn Jeremy P. (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Granted 3,230 shares
@ $0
Granted 5,295 options to buy
@ $31.71, valued at
$167.9k
|
|
| 01/30/2018 |
4
| Springhorn Jeremy P. (Director) has filed a Form 4 on uniQure N.V.|
Txns:
| Granted 4,792 shares
@ $0
Granted 6,390 options to buy
@ $19.39, valued at
$123.9k
|
|
| 12/15/2017 |
4
| Springhorn Jeremy P. (Chief Business Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Bought 15,000 shares
@ $9.084, valued at
$136.3k
|
|
| 11/14/2017 |
4
| Springhorn Jeremy P. (Chief Business Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $11.65, valued at
$1.7M
Granted 50,000 options to buy
@ $11.65, valued at
$582.5k
|
|
| 11/14/2017 |
3
| Springhorn Jeremy P. (Chief Business Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 09/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |